Perceptive Informatics today announced that it has selected TIBCO Software Inc. (NASDAQ: TIBX) to enhance its suite of eClinical service offerings, incorporating enterprise infrastructure software, TIBCO ActiveMatrix BusinessWorks™, as well as TIBCO Enterprise Message Service™, into its eClinical platform. The TIBCO solution provides integration of software applications and real-time data exchange capabilities across Perceptive’s eClinical Suite to help its customers make more effective decisions about their clinical development programs.
The new capabilities bring further performance improvements to Perceptive’s eClinical platform including reporting, integration, and identity management solutions, which enable applications of its eClinical Suite. The TIBCO solution will enable Perceptive to provide its customers with improved application integration efficiency, with greater standardization and reduced implementation timeframes.
TIBCO ActiveMatrix BusinessWorks™ brings enhanced capabilities to Perceptive’s common framework for integrating and synchronizing systems and web-based services. In combining TIBCO’s orchestration and integration technologies with its extensive experience, Perceptive is delivering hundreds of solutions integrations for its customers to help improve data quality, streamline workflow, and enable a fully standardized integration process.
The eClinical Suite from Perceptive Informatics provides advanced integration and interoperability among systems, including the IMPACT® Clinical Trial Management System (CTMS), the Medical Imaging tracking application, the DataLabs® EDC solution, and the ClinPhone® Randomization and Trial Supply Management (RTSM) technologies. The Suite supports real-time data interchange and enables diverse applications to work synergistically. For more information about Perceptive’s eClinical Suite visit: http://www.perceptive.com/Solutions/eClinical-Suite.html.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.